Showing results (1111-1120 of 5,693) with videos related to

Sort By:
Pageof 570
The Oncologist|August 18, 2018
Randomized, Open-Label Phase II Study Comparing Capecitabine-Cisplatin Every 3 Weeks with S-1-Cisplatin Every 5 Weeks in Chemotherapy-Naïve Patients with HER2-Negative Advanced Gastric Cancer: OGSG1105, HERBIS-4A TrialHisato Kawakami, Atsushi Takeno, Shunji Endo, et al.
The Oncologist|August 25, 2018
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast CancerReva K Basho, Clinton Yam, Michael Gilcrease, et al.
The Oncologist|August 25, 2018
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing ParadigmRebecca C Arend, Michael D Toboni, Allison M Montgomery, et al.
The Oncologist|June 12, 2019
POETIC (Program for Enhanced Training in Cancer): An Initial Experience of Supporting Capacity Building for Oncology Training in Sub-Saharan AfricaMadeleine Fish, Jeannette Parkes, Nazima Dharsee, et al.
The Oncologist|October 18, 2012
Continuing single-agent bevacizumab as maintenance therapy after induction XELOX (or FOLFOX) plus bevacizumab in first-line treatment of metastatic colorectal cancerEduardo Díaz-Rubio, Filippo Pietrantonio, Filippo de Braud
The Oncologist|March 22, 2015
Aprepitant and fosaprepitant: a 10-year review of efficacy and safetyMatti Aapro, Alexandra Carides, Bernardo L Rapoport, et al.
The Oncologist|March 25, 2015
Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variablesMing Sze, Phyllis Butow, Melanie Bell, et al.
The Oncologist|January 31, 2023
Evidence Regarding Pharmacogenetics in Pain Management and CancerD Max Smith, William D Figg
The Oncologist|January 31, 2023
The Association Between Medication Use in Older Women with Early-Stage Operable Primary Breast Cancer and Decision Regarding Primary TreatmentNatalie Tse, Ruth M Parks, Holly M Holmes, et al.
The Oncologist|February 6, 2023
Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and OpportunitiesAhmed M Mahmoud, Reza Nabavizadeh, Rodrigo Rodrigues Pessoa, et al.
Pageof 570